6-K

TRANSACTION IN OWN SHARES

Company: Indivior Pharmaceuticals, Inc.
Filed: March 8, 2024
Period of Report: March 8, 2024
Accession Number: 0001654954-24-002862

View Document ↗ View on SEC.gov ↗